Effect of Lubricating Gel for Pain Relief During Speculum Examination in Gynecologic Oncology Patients
1 other identifier
interventional
100
1 country
1
Brief Summary
Pelvic examination, an important part of gynecologic oncology patients to help detect cancers recurrence or infections.Despite its importance, many women are reluctant and anxious about the procedure because of fear, as well as discomfort and pain. The objective of this study is to estimate whether using lubricating gel decreases patient pain during speculum insertion compared with using water in gynecologic oncology patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Nov 2013
Shorter than P25 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 12, 2013
CompletedFirst Posted
Study publicly available on registry
November 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedJune 13, 2014
June 1, 2014
6 months
November 12, 2013
June 12, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
During Speculum Examination Dilatation stage
During Speculum Examination Dilatation stage
Secondary Outcomes (1)
visual analog scale insertion stage
uring Speculum Examination insertion stage
Other Outcomes (1)
VAS score extraction
Durig extraction the speculum
Study Arms (2)
Lubricating Gel
EXPERIMENTALThe speculum was warmed, and patients were informed about what was going to happen. The labia were spread from below to introduce the speculum, which was inserted at a 45-degree angle pointing downward then rotated horizontally as the insertion continued. A VAS score (insertion) was obtained at this point. Next, the bill of the speculum was opened up until the vaginal cuff could be seen, and the speculum was secured by turning the thumbnut. A second VAS score (dilation) was recorded. During speculum examination, cervical smear with cervical brush was obtained for pathologic assessment if necessary. The speculum was withdrawn slightly, which allowed the bill to close together, and at this stage (extraction) the final VAS score was obtained. In the gel group , a doctor placed 6,5 mL mL sterile lubricating gel on the top and bottom blades of the speculum. Length of the vagina was measured by the index finger.
water
PLACEBO COMPARATORA VAS score (insertion) was obtained at this point. Next, the bill of the speculum was opened up until the vaginal cuff could be seen, and the speculum was secured by turning the thumbnut. A second VAS score (dilation) was recorded. During speculum examination, cervical smear with cervical brush was obtained for pathologic assessment if necessary. The speculum was withdrawn slightly, which allowed the bill to close together, and at this stage (extraction) the final VAS score was obtained. In the water group the speculum's top and bottom blades were moistened with 6,5 mL tap water previously loaded into a syringe kept at room temperature.After the speculum examination, pelvic examination was performed and length of the vagina (defined as distance from vaginal cuff to vaginal apex) was measured by the index finger.
Interventions
Eligibility Criteria
You may qualify if:
- \*Female patients WHO came for surveillance for malignant gynecologic disease such as uterine cancer, cervix cancer, and ovarian cancer with or without radiotherapy and chemotherapy
You may not qualify if:
- Women were undergoing Vulvectomy or Vaginectomy
- Women with narrow vagina for standard medium size of speculum for examination
- Women who underwent fertility sparing surgery.
- Women had vaginitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tepecik Education and REserch Hospital
Izmir, Tepecik, 35600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D
Study Record Dates
First Submitted
November 12, 2013
First Posted
November 19, 2013
Study Start
November 1, 2013
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
June 13, 2014
Record last verified: 2014-06